Handbook on Agriculture, Biotechnology and Development
Show Less

Handbook on Agriculture, Biotechnology and Development

Edited by Stuart J. Smyth, Peter W.B. Phillips and David Castle

This book is a compendium of knowledge, experience and insight on agriculture, biotechnology and development. Beginning with an account of GM crop adoptions and attitudes towards them, the book assesses numerous crucial processes, concluding with detailed insights into GM products. Drawing on expert perspectives of leading authors from 57 different institutions in 16 countries, it provides a unique, global overview of agbiotech following 20 years of adoption. Many consider GM crops the most rapid agricultural innovation adopted in the history of agriculture. This book provides insights as to why the adoption has occurred globally at such a rapid rate.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 4: The private sector: MNEs and SMEs

Jill E. Hobbs


Private sector contributions to the development and growth of agricultural biotechnology (agbiotech) are comprised of those arising from a relatively small number of large Multinational Enterprises (MNEs) together with the output of numerous innovative Small and Medium-Sized Enterprises (SMEs). This chapter explores the major drivers of industry structure and firm behaviour in the agbiotech sector. Key themes include mergers, acquisitions and increasing industry concentration among MNEs, entrepreneurship and the management of knowledge resources, and an ever-evolving pattern of alliances and networks. The chapter explores various models and methods that have been used to examine these issues. Multinational Enterprises, also commonly called Multinational Corporations (MNCs), are large firms that operate across national boundaries in more than one country, often with a diverse portfolio of products. In the context of agbiotech, the dominant MNEs acted strategically in the 1990s to position themselves as life-science companies operating across pharmaceutical, agriculture-related, and nutrition or consumer portfolios, with significant investments in the application of biotechnology to seeds, crop protection, animal health and human health. In contrast, Small and Medium-Sized Enterprises (SMEs) are firms whose number of employees and turnover fall below certain limits.

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.